Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Innate Pharma S.A. - American Depositary Shares
(NQ:
IPHA
)
2.050
-0.110 (-5.09%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
48,484
Open
2.080
Bid (Size)
1.960 (2)
Ask (Size)
2.040 (2)
Prev. Close
2.160
Today's Range
2.025 - 2.100
52wk Range
1.290 - 3.511
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Innate Pharma to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
December 20, 2024
From
Innate Pharma SA
Via
Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 16, 2024
Via
Benzinga
Performance
YTD
-24.63%
-24.63%
1 Month
+25.77%
+25.77%
3 Month
-6.82%
-6.82%
6 Month
+1.49%
+1.49%
1 Year
-22.93%
-22.93%
More News
Read More
Why Edgewise Therapeutics Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket
December 16, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 09, 2024
Via
Benzinga
Innate Pharma Presents Lacutamab Improved Health-related Quality of Life Data at ASH 2024 From TELLOMAK Phase 2 Study in Patients With Cutaneous T Cell Lymphoma
December 09, 2024
From
Innate Pharma SA
Via
Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 06, 2024
Via
Benzinga
Innate Pharma and the Institute for Follicular Lymphoma Innovation (IFLI) Announce up to $7.9M Investment From IFLI to Support IPH6501 Development in Follicular Lymphoma
December 06, 2024
From
Innate Pharma SA
Via
Business Wire
Innate Pharma Highlights Abstracts Selected for the ASH Annual Meeting 2024
December 03, 2024
From
Innate Pharma SA
Via
Business Wire
Innate Pharma Releases Its 2025 Financial Calendar
November 20, 2024
From
Innate Pharma SA
Via
Business Wire
Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET® IPH6501
November 19, 2024
From
Innate Pharma SA
Via
Business Wire
Innate Pharma Reports Third Quarter 2024 Business Update and Financial Results
November 13, 2024
From
Innate Pharma SA
Via
Business Wire
Innate Pharma Highlights Data From Its Innovative Oncology Portfolio Selected for the SITC Annual Meeting 2024
November 08, 2024
From
Innate Pharma SA
Via
Business Wire
Innate Pharma Announces Conference Call and Webcast for Third Quarter 2024 Results and Business Updates
November 07, 2024
From
Innate Pharma SA
Via
Business Wire
Innate Pharma Announces Its Participation in Upcoming Investor Conferences
October 29, 2024
From
Innate Pharma SA
Via
Business Wire
Boeing, Nurix Therapeutics And 3 Stocks To Watch Heading Into Monday
October 14, 2024
Via
Benzinga
Innate Pharma Appoints Jonathan Dickinson as New Chief Executive Officer and Chairman of the Executive Board
October 14, 2024
From
Innate Pharma SA
Via
Business Wire
Innate Pharma to Host KOL Scientific Symposium on Immunotherapy in New York on October 3, 2024
September 30, 2024
From
Innate Pharma SA
Via
Business Wire
Innate Pharma Announces FDA Clearance of the IND for IPH4502, a Nectin-4 ADC to Be Developed in Solid Tumors
September 23, 2024
From
Innate Pharma SA
Via
Business Wire
Innate Pharma Reports First Half 2024 Business Update and Financial Results
September 12, 2024
From
Innate Pharma SA
Via
Business Wire
Innate Pharma SA: Monalizumab Data From NeoCOAST-2 Phase 2 Study in Early-Stage NSCLC Presented at the WCLC 2024
September 09, 2024
From
Innate Pharma SA
Via
Business Wire
Innate Pharma Announces Conference Call and Webcast for First Half 2024 Financial Results and Business Update
September 05, 2024
From
Innate Pharma SA
Via
Business Wire
Innate Pharma Announces Its Participation in the H.C. Wainwright 26th Annual Global Investment Conference
September 04, 2024
From
Innate Pharma SA
Via
Business Wire
Innate Pharma Announces Its Participation in Upcoming Investor Conference
August 01, 2024
From
Innate Pharma
Via
Business Wire
Number of Shares and Voting Rights of Innate Pharma as of July 10, 2024
July 25, 2024
From
Innate Pharma SA
Via
Business Wire
Number of Shares and Voting Rights of Innate Pharma as of June 10, 2024
June 18, 2024
From
Innate Pharma SA
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.